Biogen Inc. buy Royal Bank of Canada
Start price
05.03.24
/
50%
€201.60
Target price
05.03.25
€334.73
Performance (%)
-34.05%
End price
06.03.25
€132.95
Summary
This prediction ended on 06.03.25 with a price of €132.95. Massive losses of -34.05% were the result for the BUY prediction by Royal_Bank_of_Canada. Royal_Bank_of_Canada has a follow-up prediction for Biogen Inc. where he still thinks Biogen Inc. is a Buy. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | 6.289% | 6.289% | -42.633% |
| iShares Core DAX® | -1.165% | -0.351% | 29.372% |
| iShares Nasdaq 100 | 1.585% | 4.605% | 15.331% |
| iShares Nikkei 225® | 1.992% | -2.018% | 3.699% |
| iShares S&P 500 | 2.158% | 4.638% | 10.756% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $364.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten